The U.S. Food and Drug Administration has approved AstraZeneca and partner Daiichi Sankyo's precision drug to treat a type of breast cancer, the health regulator said on Friday. December 24 ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback